Polymer From Ethylenic Monomers Only Patents (Class 424/78.31)
-
Publication number: 20120003271Abstract: A biocompatible polymer mixture for use as a matrix for cellular attachment includes a mixture of at least two polymers selected from the group consisting of: chitosan (CS), polyethylenimine (PEI), poly(L-lactic acid) (PLLA), poly(D-lactic acid) (PDLA), poly(2-hydroxy ethyl methacrylate) (PHEMA), poly(?-caprolactone) (PCL), poly(vinyl acetate) (PVAc), poly(ethylene oxide) (PEO), poly[(R)-3-hydroxybutyric acid)] (PHB), cellulose acetate (CA), poly(lactide-co-glycolide) (PLGA) and poly(N-isopropylacrylamide) (PNIPAM). Implants making use of the polymer mixtures can support cell attachment, growth and differentiation, and tissue regeneration in vivo.Type: ApplicationFiled: September 1, 2009Publication date: January 5, 2012Applicant: The University Court of th University of EdinburghInventors: Mark Bradley, Ferdous Khan, Richard O.C. Oreffo, Rahul Shrikant Tare
-
Patent number: 8088732Abstract: The invention is directed to novel cellular factor-containing solution compositions (referred to herein as “CFS” compositions), including novel sustained-release cellular factor-containing solution compositions (referred to herein as “SR-CFS” compositions), methods of making such novel compositions and uses thereof.Type: GrantFiled: February 3, 2010Date of Patent: January 3, 2012Assignee: StemnionInventors: Vivienne S. Marshall, Charlotte A. Smith, Catherine J. Trumpower, George L. Sing, Linda O. Palladino
-
Patent number: 8066978Abstract: Disclosed herein is a biopolymer/gene complex for the aerosol delivery of a gene. The biopolymer/gene complex comprises a polyethyleneimine (PEI) having a substitution of glucose for at least a portion of the primary amino groups of the polyethyleneimine, and the content of the polyethyleneimine is 2-4 times the content of the gene. Also, disclosed is a lung cancer therapeutic agent comprising a biopolymer/gene complex including a polyethyleneimine (PEI) having a substitution of glucose for 30-40 mol % of the primary amino groups of the polyethyleneimine, and a gene encoding PTEN, in which the content of the polyethyleneimine is 2-4 times the content of the gene.Type: GrantFiled: March 23, 2005Date of Patent: November 29, 2011Assignee: Seoul National University Industry FoundationInventors: Myoung Haing Cho, Chong Su Cho
-
Publication number: 20110280825Abstract: The invention features extracorporeal methods for the treatment of a subject having a pregnancy related hypertensive disorder, such as pre-eclampsia or eclampsia. The invention also features devices used for the extracorporeal treatment of subjects have a pregnancy related hypertensive disorder, such as pre-eclampsia or eclampsia.Type: ApplicationFiled: May 13, 2011Publication date: November 17, 2011Applicant: Beth Israel Deaconess Medical CenterInventor: S. Ananth Karumanchi
-
Publication number: 20110268689Abstract: Photo-crosslinkable antifouling compositions, in particular antibacterial, antifungal and anti-algae ones, which include the combination of at least one telechelic oligoisoprene of a particular formula with an agent for crosslinking the oligoisoprene. The antifouling film is obtained by applying a thin layer of such a liquid composition on a substrate and is crosslinked at room temperature by exposure to visible and/or UV radiations. The film can be used for preventing the occurrence of a biofilm on any surface in a humid or aqueous environment, and can be used as an additive for preparing materials with a view to imparting bacteriostatic and/or bactericidal properties thereto.Type: ApplicationFiled: October 8, 2009Publication date: November 3, 2011Applicants: UNIVERSITE DU MAINEInventors: Claude Bunel, Irene Campristron, Claire Hellio, Rachid Jellali, Albert Laguerre, Jean-Luc Mouget, Jean-Francois Pilard
-
Patent number: 8048407Abstract: A method and composition for treating arteriovenous malformations (AVMs), or abnormal vasculature in the body are provided. The method comprises introducing into the region of an AVM a composition comprising a nucleophilic component, such as a thiol, and a component containing a conjugated unsaturated bond, such as an acrylate through a catheter, whereby the composition crosslinks within the body to block or occlude the AVM.Type: GrantFiled: April 26, 2004Date of Patent: November 1, 2011Inventors: Brent Vernon, Merrill Birdno, Mark C. Preul
-
Publication number: 20110243882Abstract: An aqueous antibacterial polymer emulsion and coating compositions are provided. The aqueous antibacterial polymer emulsion comprising a polymer A, an oxidant and a metal complexed with a copolymer B comprising heterocyclic containing monomers; wherein the metal is selected from copper, silver, gold, tin, zinc and combinations thereof; and wherein the emulsion is heat stable. The coating compositions made therefrom provide persistent, broad spectrum antibacterial activity without discoloration problem upon exposure to heat and/or sun light.Type: ApplicationFiled: March 31, 2011Publication date: October 6, 2011Inventors: Xiangting Dong, Shuang Liang, Tao Wang, Qingwei Zhang
-
Publication number: 20110243883Abstract: The present invention provides branched polymers which can be used as lubricants or shock absorbers in vivo. For example, the inventive polymers can be used as viscosupplements, viscoelastics, tissue space fillers, and/or anti-adhesive agents. Also provided are pharmaceutical compositions comprising the inventive polymers and methods of using them including, for example, in the treatment of arthritic and sport-injured knee joints; in reconstruction or cosmetic procedures, intervertebral disc repair, treatment of vocal cord problems, treatment of urinary incontinence, and prevention of adhesion formation following abdominal or gynecological surgery.Type: ApplicationFiled: October 31, 2008Publication date: October 6, 2011Applicant: TRUSTEES OF BOSTON UNIVERSITYInventors: Mark W. Grinstaff, Michel Wathier, Neel Joshi, Stephanie Stoddart
-
Publication number: 20110236344Abstract: The present invention relates to new synthetic receptors. More particularly, the present invention relates to the use of the synthetic receptors for delivering a protein, peptide, drug, prodrug, lipid, nucleic acid, carbohydrate or small molecule into a target cell via receptor-mediated endocytosis. According to the invention, novel synthetic mimics of cell surface receptors have been designed and methods for use of the same are disclosed.Type: ApplicationFiled: January 7, 2011Publication date: September 29, 2011Applicant: THE PENN STATE RESEARCH FOUNDATIONInventor: Blake R. Peterson
-
Publication number: 20110223128Abstract: The present invention provides compositions and methods to regulate embolic occlusion of the microvasculature. In particular, the present invention inhibits extravasation of emboli from microvasculature resulting in increased occlusion (e.g., by administering a MMP 2/9 inhibitor locally to a subject).Type: ApplicationFiled: March 10, 2011Publication date: September 15, 2011Applicant: Northwestern UniversityInventors: Jaime Grutzendler, Carson K. Lam, Taehwan Yoo
-
Publication number: 20110217379Abstract: There are disclosed magnetic nanoparticles and embolisation compositions comprising the nanoparticles. There are also disclosed methods to make the nanoparticles and embolisation compositions and methods to deliver therapeutic agents to a subject.Type: ApplicationFiled: March 4, 2011Publication date: September 8, 2011Applicant: Davis LLPInventors: Yixiang Wang, Ken Cham-Fai Leung, Chris Hon Ki Cheng, Ling Qin
-
Publication number: 20110212172Abstract: The invention provides a method of ameliorating systemic inflammation in a patient involving administering to the patient a therapeutically effective dose of composition including polystyrene divinyl benzene copolymer and a polyvinyl pyrrolidone polymer. More particularly, the method relates to using these polymers as an enteral sorbent preparation to remove inflammatory mediators, such as cytokines, from the intestinal lumen. The polymers can be in the form of a preparation of polystyrene divinyl benzene copolymer beads with a biocompatible polyvinyl pyrrolidone polymer coating.Type: ApplicationFiled: October 2, 2009Publication date: September 1, 2011Applicant: University of Pittsburgh - Of the Commonwealth System of Higher EducationInventors: John A. Kellum, Mitchell P. Fink
-
Publication number: 20110212178Abstract: Described herein are apparatus, compositions, systems and associated methods to occlude structures and malformations with radiopaque hydrogel filaments with delayed controlled rates of expansion permitting the repositioning of the device once inside the structure or malformation. Further described is a device for implantation in an animal comprising a difunctional, low molecular weight ethylenically unsaturated shapeable macromer; an ethylenically unsaturated monomer; and a radiopaque element, wherein said device contains no support members. Methods of forming such devices are also disclosed.Type: ApplicationFiled: September 24, 2010Publication date: September 1, 2011Inventors: Michael J. Constant, Gregory M. Cruise, E. Michael Keeley, Alejandro Berenstein
-
Publication number: 20110195042Abstract: The present disclosure describes methods for enhancing an overall cooling sensation of an oral mucosa comprising administering a liquid composition comprising a thickening agent and/or a mucoadhesive polymer, a non-menthol coolant; and contacting the oral mucosa with the liquid composition. The disclosure also describes the liquid compositions.Type: ApplicationFiled: February 7, 2011Publication date: August 11, 2011Inventors: Thomas Edward Huetter, Tracy L. Grosick
-
Publication number: 20110189287Abstract: The present invention relates to methods and compositions for wound healing. In particular, the present invention relates to promoting and enhancing wound healing by utilizing cross-linker covalent modification molecules to attach and deliver wound active agents to a wound. In addition, the present invention provides methods and compositions utilizing oppositely charged polyelectrolytes to form a polyelectrolyte layer on a wound surface. The invention further relates to incorporating wound active agents into a polyelectrolyte layer for delivery to a wound.Type: ApplicationFiled: February 10, 2011Publication date: August 4, 2011Inventors: Nicholas L. Abbott, Ankit Agarwal, Christopher J. Murphy, Jonathan F. McAnulty
-
Patent number: 7988956Abstract: Poly(ethylene glycol) carbamate derivatives useful as water-soluble pro-drugs are disclosed. These degradable poly(ethylene glycol) carbamate derivatives also have potential applications in controlled hydrolytic degradation of hydrogels. In such degradable hydrogels, drugs may be either trapped in the gel and released by diffusion as the gel degrades, or they may be covalently bound through hydrolyzable carbamate linkages. Hydrolysis of these carbamate linkages releases the amine drug at a controllable rate as the gel degrades.Type: GrantFiled: September 14, 2009Date of Patent: August 2, 2011Assignee: Nektar TherapeuticsInventors: Michael D. Bentley, Xuan Zhao
-
Publication number: 20110177021Abstract: The present invention relates to a method for forming a temporary obstruction of the intestine of a mammal, using a solidifiable composition, said composition being flow-able and solidifiable to form a solid plug at a desired site within the intestine, the structure of said plug being changeable in order to allow for the subsequent, at least partial removal of the obstruction.Type: ApplicationFiled: January 13, 2011Publication date: July 21, 2011Inventor: Georg BISCHOF
-
Publication number: 20110165114Abstract: There is provided a non-water soluble drug delivery composition comprising a conjugate and a polymer matrix wherein exposure of the composition to electromagnetic radiation at a suitable pre-determined wavelength and intensity induces release of the active ingredient from the composition. The conjugate is attached to the polymer matrix through non-covalent interactions. There is also provided a drug delivery apparatus formed from the drug delivery composition.Type: ApplicationFiled: May 28, 2009Publication date: July 7, 2011Inventors: Colin Peter McCoy, Sean Patrick Gorman, David Simon Jones
-
Publication number: 20110165210Abstract: A composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent is provided. A method of making a composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent, said method comprising admixing a biocompatible and pliable material with a physiologically acceptable suspending agent, is also provided. A method of augmenting soft tissue to provide long-term reduction of a skin defect, said method comprising stimulating collagen beneath the skin defect is further provided.Type: ApplicationFiled: March 15, 2011Publication date: July 7, 2011Inventor: Ayman BOUTROS
-
Publication number: 20110152083Abstract: The present invention provides for a household, agricultural, coating or personal care product composition containing the crosslinked reaction product of a network composition the reaction product of: (i) at least one anionic polymerizable ethylenically unsaturated monomer (I) selected from the group consisting of [CH2?C(R3)C(O)OXa(C2H4O)b(C3H6O)c(C4H8O)d]pP(O)(OY)q(OZ)r where R3?H or alkyl of 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a is 0 to about 100; b is 0 to about 100; c is 0 to about 100; d is 0 to about 100; q is 0 to about 2; r is 0 to about 2; p is 1 to about 3 subject to the limitation that p+q+r=3; and Y and Z is H, or metal ion; and CH2?C(R3)C(O)OXa?(C2H4O)b?(C3H6O)c?(C4H8O)d?—SO3—Y) where R3?H or alkyl of from 1 to about 6 carbon atoms; X=alkyl, aryl, or alkaryl diradical connecting group of 0 to about 9 carbon atoms; a? is 0 to about 100; b? is 0 to about 100; c? is 0 to about 100; d? is 0 to about 100; Y is HType: ApplicationFiled: December 22, 2010Publication date: June 23, 2011Applicant: Momentive Performance Materials Inc.Inventors: Ning Lu, Sigfredo Gonzalez, Emie M. Silvestre, Geng Wang
-
Patent number: 7964217Abstract: This invention relates to hydrolytically degradable gels of crosslinked poly(ethylene) glycol (PEG) structures. Addition of water causes these crosslinked structures to swell and become hydrogels. The hydrogels can be prepared by reacting two different PEG derivatives containing functional moieties at the chain ends that react with each other to form new covalent linkages between polymer chains. The PEG derivatives are chosen to provide covalent linkages within the crosslinked structure that are hydrolytically degradable. Hydrolytic degradation can provide for dissolution of the gel components and for controlled release of trapped molecules, including drugs. Reagents other than PEG can be avoided. The hydrolysis rates can be controlled by varying atoms adjacent to the hydrolytically degradable functional groups to provide substantially precise control for drug delivery in vivo.Type: GrantFiled: October 14, 2003Date of Patent: June 21, 2011Assignee: Nektar TherapeuticsInventor: J. Milton Harris
-
Publication number: 20110142788Abstract: Provided herein is an anhydrous cosmetic composition comprising at least one organic structuring agent, at least one modified starch, at least one wood meal, at least one surfactant, and at least one anhydrous liquid phase. Also provided is a method for cleansing and/or conditioning keratin materials, comprising applying at least one of the anhydrous cosmetic compositions to the keratin materials.Type: ApplicationFiled: November 12, 2010Publication date: June 16, 2011Inventors: Céline SELLIER, Gérard Gabin
-
Publication number: 20110135593Abstract: The present invention provided a polymer and a method for preparing the polymer, wherein the polymer was a terpolymer having a molecular weight of more than 1000, and copolymerized by acrolein, acrylic acid, and low alkene-alkyl dibasic acid or low-alkene-alkyl polybasic acid.Type: ApplicationFiled: June 22, 2009Publication date: June 9, 2011Applicant: QINGDAO CONTINENT PHARMACEUTICAL CO. LTD.Inventors: Shengzhang Yin, Qiaoleng Wang, Zhiyong Zhang
-
Publication number: 20110135744Abstract: There are provided compositions and methods to disperse mucin and/or actin using nanoparticles wherein the average diameter of the nanoparticles is less than about 1000 nm.Type: ApplicationFiled: December 2, 2010Publication date: June 9, 2011Inventors: Wei-Chun Chin, Eric Yi-Tong Chen, Yung-Chen Wang
-
Publication number: 20110126767Abstract: The invention relates to a method for hatching of hatchery eggs comprising: (a) treating the egg shell surface with a coating composition comprising a coating agent, to form a coating on the surface of the egg's shell; and (b) incubating the egg under conditions to cause hatching to occur; wherein the yield of hatching of said hatchery eggs is improved as compared to control eggs not treated as defined in (a). The invention additionally relates to a composition for treating of hatchery eggs prior to incubation, wherein said composition comprising a coating agent, and wherein said composition improves the hatching yield of said hatchery eggs.Type: ApplicationFiled: January 10, 2008Publication date: June 2, 2011Applicant: NATRATEC INTERNATIONAL LTD.Inventors: Jacob Lahav, Emil Polyansky, Shaul Naschitz
-
Publication number: 20110123621Abstract: The present invention relates to a method of forming shape-retentive and shape-conforming aggregate wound dressings and biomaterials composed of gel nanoparticles and wound or bodily fluid in which the aggregates are held together by non-covalent bond physical forces such as, without limitation, hydrophobic-hydrophilic interactions and hydrogen bonds. The method comprises introducing a dry powder of gel nanoparticles to a wound site in which the nanoparticles absorb some of the blood or wound exudate and coalesce in situ into the claimed shape-retentive aggregate dressing. The method also comprises introducing the dry nanoparticle powder in or on a wet bodily tissue in vivo to form the claimed shape-retentive biomaterial. In addition, the method also comprises incorporating biomedical agents to produce medicated aggregate dressings or biomaterials for a variety of medical applications. This invention also relates to uses of the method of formation of the shape-retentive aggregates of gel nanoparticles.Type: ApplicationFiled: October 8, 2010Publication date: May 26, 2011Inventors: John St. John, Daniel G. Moro
-
Publication number: 20110097420Abstract: Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component comprising a polymerizable resin comprising ethylenic unsaturated double bond, a second component comprising a compound comprising more than one type of amine selected from the group consisting of primary amines, secondary amines, tertiary amines and quaternary amines, and, optionally, the cement product includes a bioactive component to promote bone formation.Type: ApplicationFiled: December 30, 2010Publication date: April 28, 2011Applicant: Angstrom MedicaInventors: Juchui Ray Lin, Edward S. Ahn, Hansen Yuan, Paul J. Mraz
-
Patent number: 7932324Abstract: The present invention relates to novel block polymers comprising at least one first block and at least one second block that are incompatible with each other, have different glass transition temperatures (Tg), and are linked together via an intermediate segment comprising at least one constituent monomer of the at least one first block and at least one constituent monomer of the at least one second block. The block polymer has a polydispersity index I of greater than 2. The invention also relates to cosmetic compositions comprising the block polymers and processes for their use.Type: GrantFiled: September 21, 2007Date of Patent: April 26, 2011Assignee: L'OrealInventors: Bertrand Lion, Nathalie Martin, Béatrice Toumi
-
Publication number: 20110091538Abstract: The present invention provides a Monodisperse Polymer Particles (MPP) adapted to release alkoxy groups by means of a hydrolyser, such that Monodisperse Bioactive Polymer Particles (MBPP) are obtained in vivo. The MBPP are characterized by (a) at least one naturally occurring or synthetic long molecular chain consisting of biologically stable backbones optionally crosslinked, further characterized by a molecular weight of at least 1 KD, comprising between 10 to 1,000,000 repeated covalently-linked small molecules with a functionality of at least one alkoxy releasing group per molecule; (b) a long dimension between 0.1 and 10 micrometers; and, (c) a zeta potential value of 30 to 130 mV at pH of about 7.0. The MBPP alter, inhibit, activate, induce or otherwise affect biological or chemical events in vivo.Type: ApplicationFiled: June 16, 2009Publication date: April 21, 2011Applicant: Z.H.T. ENGINEERING EQUIPMENT AND TECHNOLOGIES LTD.Inventor: Benzion Geshuri
-
Publication number: 20110091540Abstract: A combination of active agents is disclosed which are particularly useful for treating fluid overload conditions. Methods for using the combination of active agent are also disclosed. The combination can include a highly absorbent polyelectrolyte polymer along with an agent that increases the amount of fluid in the intestine.Type: ApplicationFiled: August 29, 2008Publication date: April 21, 2011Inventors: Alan Strickland, George Grass
-
Publication number: 20110091554Abstract: The invention relates to a new injectable composite material suitable for use as a bone substitute. The composite material according to the invention comprises a reactive ceramic phase based on tricalcium phosphate and an organic phase comprising a polyvinyl alcohol hydrogel. By varying the concentration of the two phases it is possible to modulate the mechanical and injectability properties of the material.Type: ApplicationFiled: December 28, 2010Publication date: April 21, 2011Applicant: CONSIGLIO NAZIONALE DELLE RICERCHEInventors: Luigi AMBROSIO, Valeria SANGINARIO, Maria Pau GINEBRA, Josep Anton PLANELL
-
Publication number: 20110070277Abstract: A lotion composition applied on the body facing surface of an absorbent article such as a diaper, training pant, adult incontinence product, feminine hygiene product, improves the ease of removal of feces or menses after an absorbent article comprising the lotion composition has been used and removed from the wearer. The lotion composition may also suitably be applied on a wipe.Type: ApplicationFiled: September 20, 2010Publication date: March 24, 2011Inventors: Victor Nicholas Vega, Linda Jean Bryson
-
Publication number: 20110059040Abstract: Described herein are methods of inhibiting the activity of a virus or a bacterium comprising contacting a virus or bacterium with a polymer functionalized with at least one boronic acid moiety. Also described are methods of treatment using such functionalized polymers.Type: ApplicationFiled: June 26, 2008Publication date: March 10, 2011Inventors: Patrick F. Kiser, Julie I. Jay, Meredith C. Roberts
-
Publication number: 20110052712Abstract: A formulation for generating an adhesion barrier that includes a plurality of particles or a dry powder that is made of a polymer combination of at least one biodegradable polymer and at least one water soluble polymer is disclosed. Methods of making and delivering the formulation are further disclosed. The formulation of particles is deposited on a surface of internal body tissue and the deposited formulation absorbs moisture from the tissue and forms a film over the surface. The film acts as an adhesion barrier by reducing or preventing adhesion of the surface to other body tissue.Type: ApplicationFiled: February 12, 2010Publication date: March 3, 2011Inventors: Donald J. Eaton, Bin Huang, Michael A. Savitt
-
Publication number: 20110033508Abstract: The present invention relates to elastic, hydrophilic and substantially spherical microspheres useful for dermal augmentation and tissue bulking. The invention provides injectable compositions comprising the microspheres and a biocompatible carrier for use in dermal augmentation. The present invention further provides methods of dermal augmentation and tissue bulking, particularly for the treatment of skin contour deficiencies, Gastro-esophageal reflux disease, urinary incontinence, and urinary reflux disease, using the injectable compositions.Type: ApplicationFiled: July 31, 2009Publication date: February 10, 2011Applicant: Biosphere Medical, Inc.Inventors: Jean-Marie VOGEL, Richard Thomas, Egisto Boschetti
-
Publication number: 20110020228Abstract: A method for the treatment of cancer involves delivering a surface active agent to an organism, where the surface active agent selectively partitions to and kills cancer cells as opposed to healthy cells. The surface active agent can be an ionic or a non-ionic surfactant with a HLB of less than 29 or a mixture of surface active agents with a HLB of less than 40, where the hydrophobic portion is a lesser fraction of the surface active agent than the hydrophilic portion. A fluorescence method of detecting and locating cancer cells in an organism involves delivering a surface active agent, where the surface active agent includes a fluorescence moiety that upon selective partitioning of the surface active agent to the cancer cells and irradiation by a radiation source to excite the fluorescence moiety, a fluorescence emission is observed permitting the detection and location of the cancerous tissue by local volumes of relatively high intensity emission.Type: ApplicationFiled: February 2, 2009Publication date: January 27, 2011Applicant: University of Florida Resarch Foundation, Inc.Inventors: Brij M. Moudgil, Manoj Varshney, Stephen R. Grobmyer
-
Publication number: 20110002875Abstract: Therapeutic compounds and methods for inhibiting amyloid deposition in a subject, whatever its clinical setting, are described. Amyloid deposition is inhibited by the administration to a subject of an effective amount of a therapeutic compound comprising an anionic group and a carrier molecule, or a pharmaceutically acceptable salt thereof, such that an interaction between an amyloidogenic protein and a basement membrane constituent is inhibited. Preferred anionic groups are sulfonates and sulfates. Preferred carrier molecules include carbohydrates, polymers, peptides, peptide derivatives, aliphatic groups, alicyclic groups, heterocyclic groups, aromatic groups and combinations thereof.Type: ApplicationFiled: June 8, 2010Publication date: January 6, 2011Applicant: Bellus Health (International) LimitedInventors: Robert Kisilevsky, Walter Szarek, Donald Weaver
-
Patent number: 7862800Abstract: This invention relates to sterilized cyanoacrylate adhesive compositions with x-ray imagining capabilities, methods of making such compositions, and methods of using such compositions.Type: GrantFiled: January 10, 2006Date of Patent: January 4, 2011Assignee: Henkel AG & Co. KGaAInventors: Kenneth N. Broadley, Noeleen B. Swords, Clare P. Grealis
-
Publication number: 20100330004Abstract: The invention includes a method of increasing the substantivity of a personal care composition to hair, skin or nails by preparing a composition of an aqueous phase, a non-aqueous phase and a neutralized amino acid ester that is a reaction product of a neutral amino acid having a non-polar side chain with a long chain fatty alcohol and is represented by formula (I): wherein R1 is an alkyl group; R2 is a linear or branched carbon chain; and the amine group of the amino acid is neutralized with an acid. The composition is substantially free of petrochemicals and/or derivatives of petrochemical materials. The aqueous phase and the non-aqueous phase are emulsified by the neutralized amino acid ester. Other methods and an emulsifiers that is the neutralized amino acid ester are included. Because the neutralized amino acid ester and the compositions do not contain petrochemical-derived ingredient, the products are natural.Type: ApplicationFiled: June 29, 2010Publication date: December 30, 2010Applicant: Inolex Investment CorporationInventor: Rocco Burgo
-
Publication number: 20100322982Abstract: A composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent is provided. A method of making a composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent, said method comprising admixing a biocompatible and pliable material with a physiologically acceptable suspending agent, is also provided. A method of augmenting soft tissue to provide long-term reduction of a skin defect, said method comprising stimulating collagen beneath the skin defect is further provided.Type: ApplicationFiled: October 29, 2008Publication date: December 23, 2010Inventor: Ayman Boutros
-
Publication number: 20100310615Abstract: The invention relates to compositions comprising pholyphenol derivatives, characterised in that said polyphenols contain monomers, oligomers or polymers with units having formula (I), said units being characterised by the simultaneous presence of a resorcinol nucleus (nucleus A) and a para-phenol nucleus (nucleus B) which are interconnected by a carbon bond C, said derivatives being over-activated, in respect of the nucleophilic power thereof, by alkylation of at least one phenol function of each constituent monomer unit and stabilised by sterification by mixtures of fatty acids in proportions reflecting those of vegetable oils formed mainly by unsaturated fatty acids of all of the other phenol functions. The invention is suitable for use in cosmetics, dietetics and therapeutics.Type: ApplicationFiled: November 17, 2008Publication date: December 9, 2010Inventor: Joseph Vercauteren
-
Publication number: 20100297057Abstract: Pest controlling compositions exhibiting enhanced pesticidal activity levels and methods for preparing the same are disclosed. In one embodiment, a method includes providing a liquid composition that includes at least one pesticide and at least one co-ingredient that enhances pesticidal activity of the composition compared to a composition dissimilar only in not having the at least one co-ingredient. The at least one co-ingredient may include at least one metal oxide, a combination of at least one transition metal salt and at least one proteinaceous material or a combination of at least one proteinaceous material and at least one polymeric material. The method further includes spray drying the liquid composition to provide a solid composition. In one aspect of this embodiment, the solid composition provided by the spray drying exhibits enhanced pesticidal activity compared to the liquid composition.Type: ApplicationFiled: April 27, 2010Publication date: November 25, 2010Inventors: Stephen L. Wilson, Lei Liu, James D. Thomas, Raymond E. Boucher, JR., James E. Dripps, Margaret s. Kempe, Martin C. Logan, Douglas J. Linscott, John M. Atkinson
-
Publication number: 20100291169Abstract: Anionic polyelectrolytes are used as binding agents to reduce the solubility of cationic antimicrobial polyelectrolytes. Ionic attraction between the anionic stabilizing polyelectrolytes and the antimicrobial cationic polyelectrolytes results in formation of a polyelectrolyte complex (PEC). A treatment liquid comprising a stable colloid, suspension, dispersion, solution, coacervate, or emulsion of the PEC in an aqueous carrier is used to treat an article, thus coating, infiltrating, or infusing the PEC onto or into the article. Subsequent drying results in an antimicrobial article wherein the PEC is bound to the article and is significantly less prone, relative to either of the component polyelectrolytes, to being washed, leached, leaked, extracted, or migrated from the antimicrobial article during use, or when exposed to aqueous fluids or solvents.Type: ApplicationFiled: July 2, 2010Publication date: November 18, 2010Applicant: QUICK-MED TECHNOLOGIES, INC.Inventors: William Toreki, David N. Moore, Bernd Liesenfeld, Albina Mikhaylova, Gerald M. Olderman
-
Publication number: 20100285078Abstract: A composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent is provided. A method of making a composition comprising an alloplastic injectable suspension for use as a dermal filler comprising a biocompatible and pliable material and a physiologically acceptable suspending agent, said method comprising admixing a biocompatible and pliable material with a physiologically acceptable suspending agent, is also provided. A method of augmenting soft tissue to provide long-term reduction of a skin defect, said method comprising stimulating collagen beneath the skin defect is further provided.Type: ApplicationFiled: April 30, 2010Publication date: November 11, 2010Inventor: Ayman Boutros
-
Publication number: 20100284958Abstract: The present invention provides BoNT/A peptides as well as methods of predicting or determining immunoresistance to botulinum toxin therapy in an individual using BoNT/A peptides.Type: ApplicationFiled: October 30, 2009Publication date: November 11, 2010Inventor: M. Zouhair Atassi
-
Publication number: 20100275939Abstract: An antibacterial artificial hair of the present invention includes an artificial hair and organic resin particles adhering to the artificial hair. The organic resin particles are powdered fine particles including an organic resin and an aluminum salt that is chemically bonded to the organic resin. An antibacterial coating agent for artificial hair of the present invention is used for an artificial hair and obtained by dispersing the organic resin particles in an aqueous medium. The presence of the organic resin particles including the aluminum salt not only provides the luster and texture similar to those of human hair, but also imparts the antibacterial properties.Type: ApplicationFiled: November 28, 2008Publication date: November 4, 2010Applicant: KANEKA CORPORATIONInventor: Hiroyuki Shinbayashi
-
Publication number: 20100272814Abstract: A method of producing bronchorelaxation in the lungs of a human or animal affected by airway obstruction comprises administration of a pharmacologically effective amount to the body or to the intestine of said human or animal of an agent capable of binding mercury in elemental, ionic and/or organic form present in the body or in the intestinal lumen to enhance its excretion via the feces and/or the urine. A corresponding use of the agent and its use for the manufacture of a medicament are also disclosed.Type: ApplicationFiled: December 15, 2008Publication date: October 28, 2010Applicant: Pharmalundensis ABInventor: Staffan Skogvall
-
Patent number: 7820734Abstract: The present disclosure provides lubricious antimicrobial coating vehicles for medical devices capable of reducing the coefficient of friction of such devices upon exposure thereof to moisture and imparting antimicrobial properties to said devices. The coating vehicle allows the introduction of a pharmacological additive having a release rate that is within acceptable pharmacokinetic criteria.Type: GrantFiled: October 31, 2007Date of Patent: October 26, 2010Assignee: Tyco Healthcare Group LPInventor: Diane L. McGhee
-
Publication number: 20100247478Abstract: A method for reducing the occurrence of new post-operative fractures in vertebrae of a patient's spine after a vertebroplasty procedure performed to stabilize a fracture in a vertebra of a patient comprising the steps of performing a vertebroplasty procedure to stabilize a fracture in a vertebra of the patient, wherein the vertebroplasty procedure comprises the step of injecting a material into the fractured vertebra, wherein the material is formed by mixing together a first paste and a second paste, wherein the first paste comprises at least one of a polymerizable monomer and a filler, and wherein the second paste comprises at least one of a polymerizable monomer and a filler.Type: ApplicationFiled: February 16, 2010Publication date: September 30, 2010Inventors: Theodore D. Clineff, Maarten Persenaire, Gina M. Nagvajara, Marissa M. Darmoc, Matthew B. Havener, Stephen G. Gilbert, Erik M. Erbe
-
Patent number: RE42377Abstract: A composition including 2-hexyl cyanoacrylate and gold is useful in treating arteriovenous malformations (AVMs) and other body lumens to be blocked.Type: GrantFiled: July 12, 2007Date of Patent: May 17, 2011Assignees: Stryker Corporation, Stryker NV Operations LimitedInventors: Robert E. Krall, Charles W. Kerber, Kimberly Knox